Women's Health Diagnostics Market Expected to Reach $21,502 Million, Globally, by 2023 with key players Abbott Laboratories, Becton, Dickinson and Company, Carestream Health, F. Hoffmann-La Roche AG, GE Healthcare, Hologic, Inc., Koninklijke Philips N.V.,

According to a new report published by Allied Market Research, titled, Women's Health Diagnostics Market, by Type and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global women's health diagnostics market was valued at $13,133 million in 2016, and is projected to reach $21,501 million in 2023 at a CAGR of 7.0% from 2017 to 2023.

Gynecology is the main branch of medical science concerned with women's health problems. This includes the health related disorders, their screening and testing procedures. Women are highly prone to various cancers such as breast, cervical, and ovarian cancer. Other health issues include infertility, polycystic ovarian syndrome, menopause, depression, osteoporosis, and obesity.

Get sample copy of this report at:
https://www.alliedmarketresearch.com/request-sample/4521

The diagnostic tests segment occupied the largest share in 2016, owing to the high usage, applicability, and availability of tests for detecting various disorders in women. Furthermore, the accessories and consumables segment is expected to grow at the highest CAGR of 7.8% from 2017 to 2023, and is anticipated to continue its dominance during the forecast period. The utilization rate of various women's health related diagnostics procedures for hospitals and clinics is high, however diagnostic and imaging centers segment is expected to grow at a CAGR of 7.8% during the forecast period. This is attributed to increase in incidence of various types of health-related disorders.

Key findings of the Women's Health Diagnostics Market:

• Diagnostic tests segment accounted for around 55.1% share of the global women's health diagnostics market in 2016

• Diagnostic devices segment is expected to grow at a CAGR of 6.5% from 2017 to 2023.

• Hospitals and clinics segment accounted for around 49.8% share of the global women's health diagnostics market in 2016

• North America accounted for around 33.7% share of the global women's health diagnostics market in 2016

• Asia-Pacific is expected to grow at the highest CAGR of 8.1% from 2017 to 2023

Get customized copy of this report at:
https://www.alliedmarketresearch.com/request-for-customization/4521

North America was the leading revenue contributor to the global women's health diagnostics market, accounting for nearly one-third of the global market. This is attributed to the presence of numerous screening tests for cancer detection and other diseases. Moreover, presence of key players and advanced diagnostics procedures such as 3D mammography. However, Asia-Pacific is expected to grow at the highest CAGR of 8.1% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness towards various women related disorders.

Key players:

• Abbott Laboratories
• Becton
• Dickinson and Company
• Carestream Health
• F. Hoffmann-La Roche AG
• GE Healthcare
• Hologic Inc.
• Koninklijke Philips N.V.
• Quest Diagnostics Inc.
• Cardinal Health
• Siemens AG.

Table of content:


Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Top Winning Strategies, By Year, 2014-2017
3.2.2.2. Top Winning Strategies, By Development, 2014-2017 (%)
3.2.2.3. Top Winning Strategies, By Company, 2014-2017

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Growth in geriatric female population
3.3.1.2. Increasing incidence of various chronic and lifestyle disorders in women
3.3.1.3. Rise in demand for point-of-care diagnostic testing
3.3.1.4. High adoption of imaging procedures

3.3.2. Restrains

3.3.2.1. High cost of imaging and monitoring systems
3.3.2.2. Lack of skilled professionals

3.3.3. Opportunities

3.3.3.1. Miniaturization of ultrasound devices
3.3.3.2. Untapped emerging economies

3.3.4. Impact analysis

Access Full Summary at: https://www.alliedmarketresearch.com/womens-health-diagnostics-market

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David c
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.